Ascletis

News

Measuring tape overlain on a dark yellow background

Pfizer's $2bn+ obesity bet, and other weight-loss news

Pfizer licenses another GLP-1 agonist, from YaoPharma, plus clinical updates from Zealand, Structure, Ascletis, Wave, and Boehringer Ingelheim.

News

Ascletis says oral acne drug shows "exceptional efficacy"

Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US.

News

Hong Kong biotechs IPOs face lower valuations after Ascletis...

Biotechs taking an advantage of new Hong Kong exchange rules have been told to expect lower valuations, after Chinese pioneer Ascletis Pharma’s shares plunged nearly 45% in the first month

News

Hepatitis drug wins award for cure rate and efficacy

Hepatitis C drug Ganovo won a top clinical research award due to its successful performance in a phase 3 trial.

Pfizer's $2bn+ obesity bet, and other weight-loss news

Ascletis says oral acne drug shows "exceptional efficacy"

Hong Kong biotechs IPOs face lower valuations after Ascletis...

Hepatitis drug wins award for cure rate and efficacy

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

Ascletis

Editor's Picks